A case report highlights durable disease control in a patient with POLE-mutated dedifferentiated endometrial carcinoma and brain metastases following a multidisciplinary treatment that included pembrolizumab. This finding may inform future therapeutic strategies for similar cases.
durable disease control following multidisciplinary treatment including pembrolizumab in pole mutated dedifferentiated endometrial carcinoma with brain metastases a case report
Original title: “Durable disease control following multidisciplinary treatment including pembrolizumab in POLE-mutated dedifferentiated endometrial carcinoma with brain metastases: A case report.”